Abstract
The ability to quantify motor symptom progression in Parkinson’s disease (PD) patients is crucial for assessing disease progression and for optimizing therapeutic interventions, such as dopaminergic medications and deep brain stimulation. Cumulative and heuristic clinical experience has identified various clinical signs associated with PD severity but these are neither objectively quantifiable or robustly validated. Video-based objective symptom quantification enabled by machine learning (ML) introduces a potential solution. However, video-based diagnostic tools often have implementation challenges due to expensive and inaccessible technology, often requiring multi-camera setups, pristine video collection protocols, or additional sensors that are impractical for conventional use. Additionally, typical “black-box” ML implementations are not tailored to be clinically interpretable, either due to complex and unintuitive algorithms or a lack of analysis on feature stability and optimality. Here, we address these needs by releasing a comprehensive kinematic dataset and developing a novel interpretable video-based framework that accurately predicts high versus low PD motor symptom severity according to MDS- UPDRS Part III metrics. This data driven approach validated and robustly quantified canonical movement features and identified new clinical insights, not previously appreciated as related to clinical severity. Our framework is enabled by retrospective, single-view, seconds-long videos recorded on consumer-grade devices such as smartphones, tablets, and digital cameras, thereby eliminating the requirement for specialized equipment. Following interpretable ML principles, our framework enforces robustness and interpretability by integrating (1) automatic, data-driven kinematic metric evaluation guided by pre-defined digital features of movement, (2) combination of bi-domain (body and hand) kinematic features, and (3) sparsity-inducing and stability-driven ML analysis with simple-to-interpret models. These elements in our design ensure that the proposed framework quantifies clinically meaningful motor features useful for both ML predictions and clinical analysis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RA, SL, and JLO would like to acknowledge support from the UCSF Innovation Ventures
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Privacy and confidentiality protection for this study have been explicitly addressed with the University of California, San Francisco IRB approval. The raw videos were not authorized for release.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
We have publicly released the kinematic data from 31 participants with Parkinsonism. The data is freely available at https://github.com/abbasilab/Video-Tracking-PD.
